MedTrace Logo

Sleep Apnea Screening

NCT02569749 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2015-11-03

No results posted yet for this study

Summary

To assess the incidence of Sleep Apnea-Hypopnea Syndrome (SAHS), both obstructive and central, in patients with: 1) pacemaker indication; 2) implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRTD), 3) heart failure and preserved left ventricular ejection fraction (LVEF) and 4) heart failure and reduced LVEF.

Conditions

  • Sleep Apnea/Hypopnea Syndrome

Interventions

OTHER

Berlin and Epworth questionaries

OTHER

Sleep apnea monitoring in those patients in whom a pacemaker with monitoring apnea system has been implanted.

OTHER

Night polygraph / Polysomnography

Sponsors & Collaborators

  • Arrhythmia Network Technology S.L.

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-03-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02569749 on ClinicalTrials.gov